Pranax

Houston, United States

Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.

$17.0M raised

Jan 2026

Series A

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Pranax

How much funding has Pranax raised?

Pranax has raised $17.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.

Where is Pranax headquartered?

Pranax is headquartered in Houston, United States.

What does Pranax do?

Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.

What stage is Pranax at?

Pranax is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 29, 2026.

MLA

"Pranax — Funding & Investors." VCBacked, January 29, 2026, https://www.vcbacked.co/company/pranax. Accessed June 3, 2026.

APA

VCBacked. (2026). Pranax — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/pranax

Wikipedia (cite web)

{{cite web |title=Pranax — Funding & Investors |url=https://www.vcbacked.co/company/pranax |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 29, 2026.